Pharmacytimes: Condition Center: Bipolar Disorder http://www.pharmacytimes.com/condition-resources/bipolar-disorder/condition-rss Bipolar Disorder en-us Mon, 23 Jan 2017 02:24:02 UTC Mon, 23 Jan 2017 02:24:02 UTC Ajanta Launches Generic Abilify in US Market http://www.pharmacytimes.com/product-news/ajanta-launches-generic-abilify-in-us-market Ajanta has launched aripiprazole tablets in 2.5-mg, 5-mg, 10-mg, 15-mg, 20-mg, and 30-mg doses in the United States. 7:00 AM, Tue November 29, 2016 FDA Approves sNDA for Label Changes to ADASUVE http://www.pharmacytimes.com/product-news/fda-approves-snda-for-label-changes-to-adasuve The FDA has approved the supplemental New Drug Application for label changes to ADASUVE (loxapine) inhalation powder. 7:00 AM, Mon October 24, 2016 Ideal Adherence Interventions for Bipolar Patients http://www.pharmacytimes.com/resource-centers/bipolar-disorder/ideal-adherence-interventions-for-bipolar-patients Patients diagnosed with bipolar disorder are at very high risk for medication nonadherence. 12:06 AM, Fri March 18, 2016 Adding Anticonvulsant to Antipsychotic May Benefit Bipolar Patients http://www.pharmacytimes.com/resource-centers/bipolar-disorder/adding-anticonvulsant-to-antipsychotic-may-benefit-bipolar-patients Combining lamotrigine with quetiapine may improve depressive symptoms and clinical remission rates in patients with bipolar disorder. 9:46 PM, Wed January 13, 2016 Vraylar Approved for Schizophrenia, Bipolar Disorder http://www.pharmacytimes.com/product-news/vraylar-approved-by-fda-to-treat-schizophrenia-and-bipolar The FDA has approved cariprazine (Vraylar) to treat schizophrenia and manic or mixed episodes associated with bipolar disorder. 8:46 AM, Fri September 18, 2015 Bipolar Depression: Which Drug Works Best? http://www.pharmacytimes.com/resource-centers/bipolar-disorder/bipolar-depression-which-drug-works-best Clinicians would like to have better information about treatment options for bipolar depression, but clinical trials of any length are scarce. 10:00 PM, Mon September 14, 2015 Atypical Antipsychotic Lowers Bipolar Disorder Treatment Costs http://www.pharmacytimes.com/resource-centers/bipolar-disorder/atypical-antipsychotic-lowers-bipolar-disorder-treatment-costs In the recent past, bipolar disorder has been classified as the most costly mental illness. 10:52 PM, Mon August 31, 2015 Self-Monitoring Strategies for Bipolar II Disorder http://www.pharmacytimes.com/resource-centers/bipolar-disorder/self-monitoring-strategies-for-bipolar-ii-disorder Patients with bipolar disorder who have lingering levels of symptoms and instable moods between episodes often relapse and require hospitalization. 12:41 AM, Mon August 17, 2015 Does Temperament Affect Bipolar Treatment Adherence? http://www.pharmacytimes.com/resource-centers/bipolar-disorder/does-temperament-affect-bipolar-treatment-adherence Current medication regimens used in bipolar I disorder produce suboptimal patient outcomes more often than not. 12:00 AM, Mon August 3, 2015 Early Application of Adherence Technology in Bipolar Disorder http://www.pharmacytimes.com/resource-centers/bipolar-disorder/early-application-of-adherence-technology-in-bipolar-disorder Poor medication adherence increases the risk of relapse, hospitalization, and suicide in patients with bipolar disorder. 10:00 PM, Mon July 13, 2015 Bipolar Disorder: When DUI Means Duration of Untreated Illness http://www.pharmacytimes.com/resource-centers/bipolar-disorder/Bipolar-Disorder-When-DUI-Means-Duration-of-Untreated-Illness Longer duration of untreated illness (DUI) has been associated with poor clinical outcomes for many mood disorders, but not specifically bipolar disorder. 11:00 PM, Thu June 25, 2015 FDA Extends Review of Resubmitted Atypical Antipsychotic http://www.pharmacytimes.com/product-news/FDA-Extends-Review-of-Resubmitted-Atypical-Antipsychotic The FDA has extended its review of Richter and Allergan's atypical antipsychotic, cariprazine, for the treatment of schizophrenia and manic or mixed episodes associated with bipolar disorder. 9:00 PM, Thu June 18, 2015 Monitor Lithium-Related Renal, Thyroid Dysfunction in Bipolar Disorder http://www.pharmacytimes.com/resource-centers/bipolar-disorder/Monitor-Lithium-Related-Renal-Thyroid-Dysfunction-in-Bipolar-Disorder Lithium remains a treatment of choice for bipolar disorder, as it is very effective in stabilizing mood and reducing suicide risk. However, its use is associated with adverse renal and thyroid effects. 2:35 AM, Wed June 3, 2015 Potential Use for N-acetylcysteine in Bipolar Disorder http://www.pharmacytimes.com/resource-centers/bipolar-disorder/Potential-Use-for-N-acetylcysteine-in-Bipolar-Disorder Favorable evidence supports the drug's utility in certain psychiatric and neurological disorders. 11:35 PM, Wed May 13, 2015 Quetiapine in Bipolar Disorder: A Decade of Evidence http://www.pharmacytimes.com/resource-centers/bipolar-disorder/Quetiapine-in-Bipolar-Disorder-A-Decade-of-Evidence The search for better treatment approaches has led clinicians to use atypical antipsychotics to augment or replace conventional approaches. 1:00 AM, Mon May 4, 2015 FDA Approves First Generic to Treat Schizophrenia, Bipolar Disorder http://www.pharmacytimes.com/resource-centers/bipolar-disorder/FDA-Approves-First-Generic-to-Treat-Schizophrenia-Bipolar-Disorder The FDA today approved the first generic versions of aripiprazole to treat schizophrenia and bipolar disorder. 4:27 AM, Tue April 28, 2015 Why Bipolar Patients Use Complementary and Alternative Medicine for Depression http://www.pharmacytimes.com/resource-centers/bipolar-disorder/Why-Bipolar-Patients-Use-Complementary-and-Alternative-Medicine-for-Depression Many patients with depressive disorders self-treat with complementary and alternative medicine. 9:00 PM, Thu April 16, 2015 Problem-Solving Skills Improve Bipolar Disorder Outcomes http://www.pharmacytimes.com/resource-centers/bipolar-disorder/Problem-Solving-Skills-Improve-Bipolar-Disorder-Outcomes Any intervention that significantly improves difficult, disabling depressive symptoms could improve quality of life for bipolar patients. 10:00 PM, Sat April 4, 2015 Readmission Penalties Should Account for Mental Illness http://www.pharmacytimes.com/resource-centers/bipolar-disorder/Readmission-Penalties-Should-Account-for-Mental-Illness Readmission rates among patients with heart failure, acute myocardial infarction, and pneumonia increase when psychiatric illness is also present. 12:00 AM, Sat April 4, 2015 Is Voluntary Bipolar Treatment as Effective as Outpatient Commitment? http://www.pharmacytimes.com/resource-centers/bipolar-disorder/Is-Voluntary-Bipolar-Treatment-as-Effective-as-Outpatient-Commitment Few studies have examined whether compulsory community treatment meets its goals of improved clinical outcomes, better social functioning, and reduced health service use. 9:00 PM, Tue March 24, 2015